BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 16042591)

  • 1. Flavocytochrome P450 BM3: an update on structure and mechanism of a biotechnologically important enzyme.
    Warman AJ; Roitel O; Neeli R; Girvan HM; Seward HE; Murray SA; McLean KJ; Joyce MG; Toogood H; Holt RA; Leys D; Scrutton NS; Munro AW
    Biochem Soc Trans; 2005 Aug; 33(Pt 4):747-53. PubMed ID: 16042591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flavocytochrome P450 BM3 and the origin of CYP102 fusion species.
    Girvan HM; Waltham TN; Neeli R; Collins HF; McLean KJ; Scrutton NS; Leys D; Munro AW
    Biochem Soc Trans; 2006 Dec; 34(Pt 6):1173-7. PubMed ID: 17073779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P450 BM3: the very model of a modern flavocytochrome.
    Munro AW; Leys DG; McLean KJ; Marshall KR; Ost TW; Daff S; Miles CS; Chapman SK; Lysek DA; Moser CC; Page CC; Dutton PL
    Trends Biochem Sci; 2002 May; 27(5):250-7. PubMed ID: 12076537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the interactions of cytochrome b5 with flavocytochrome P450 BM3 and its domains.
    Noble MA; Girvan HM; Smith SJ; Smith WE; Murataliev M; Guzov VM; Feyereisen R; Munro AW
    Drug Metab Rev; 2007; 39(2-3):599-617. PubMed ID: 17786641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression, purification, and characterization of Bacillus subtilis cytochromes P450 CYP102A2 and CYP102A3: flavocytochrome homologues of P450 BM3 from Bacillus megaterium.
    Gustafsson MC; Roitel O; Marshall KR; Noble MA; Chapman SK; Pessegueiro A; Fulco AJ; Cheesman MR; von Wachenfeldt C; Munro AW
    Biochemistry; 2004 May; 43(18):5474-87. PubMed ID: 15122913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electron transfer in flavocytochrome P450 BM3: kinetics of flavin reduction and oxidation, the role of cysteine 999, and relationships with mammalian cytochrome P450 reductase.
    Roitel O; Scrutton NS; Munro AW
    Biochemistry; 2003 Sep; 42(36):10809-21. PubMed ID: 12962506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The bacterial P450 BM3: a prototype for a biocatalyst with human P450 activities.
    Yun CH; Kim KH; Kim DH; Jung HC; Pan JG
    Trends Biotechnol; 2007 Jul; 25(7):289-98. PubMed ID: 17532492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dimeric form of flavocytochrome P450 BM3 is catalytically functional as a fatty acid hydroxylase.
    Neeli R; Girvan HM; Lawrence A; Warren MJ; Leys D; Scrutton NS; Munro AW
    FEBS Lett; 2005 Oct; 579(25):5582-8. PubMed ID: 16214136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein engineering of the cytochrome P450 monooxygenase from Bacillus megaterium.
    Urlacher VB; Schmid RD
    Methods Enzymol; 2004; 388():208-24. PubMed ID: 15289074
    [No Abstract]   [Full Text] [Related]  

  • 10. Switching pyridine nucleotide specificity in P450 BM3: mechanistic analysis of the W1046H and W1046A enzymes.
    Neeli R; Roitel O; Scrutton NS; Munro AW
    J Biol Chem; 2005 May; 280(18):17634-44. PubMed ID: 15710617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The full-length cytochrome P450 enzyme CYP102A1 dimerizes at its reductase domains and has flexible heme domains for efficient catalysis.
    Zhang H; Yokom AL; Cheng S; Su M; Hollenberg PF; Southworth DR; Osawa Y
    J Biol Chem; 2018 May; 293(20):7727-7736. PubMed ID: 29618513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single mutation in cytochrome P450 BM3 induces the conformational rearrangement seen upon substrate binding in the wild-type enzyme.
    Joyce MG; Girvan HM; Munro AW; Leys D
    J Biol Chem; 2004 May; 279(22):23287-93. PubMed ID: 15020590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Redox characterisation of flavocytochrome P-450 BM3 from Bacillus megaterium.
    Munro AW; Daff SN; Turner KL; Chapman SK
    Biochem Soc Trans; 1997 Nov; 25(4):S628. PubMed ID: 9450056
    [No Abstract]   [Full Text] [Related]  

  • 14. Flavocytochrome P450 BM3 substrate selectivity and electron transfer in a model cytochrome P450.
    Munro AW; Noble MA; Ost TW; Green AJ; McLean KJ; Robledo L; Miles CS; Murdoch J; Chapman SK
    Subcell Biochem; 2000; 35():297-315. PubMed ID: 11192726
    [No Abstract]   [Full Text] [Related]  

  • 15. Flavocytochrome P450 BM3 mutant W1046A is a NADH-dependent fatty acid hydroxylase: implications for the mechanism of electron transfer in the P450 BM3 dimer.
    Girvan HM; Dunford AJ; Neeli R; Ekanem IS; Waltham TN; Joyce MG; Leys D; Curtis RA; Williams P; Fisher K; Voice MW; Munro AW
    Arch Biochem Biophys; 2011 Mar; 507(1):75-85. PubMed ID: 20868649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Filling a hole in cytochrome P450 BM3 improves substrate binding and catalytic efficiency.
    Huang WC; Westlake AC; Maréchal JD; Joyce MG; Moody PC; Roberts GC
    J Mol Biol; 2007 Oct; 373(3):633-51. PubMed ID: 17868686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interaction of eukaryotic cytochrome b5 with flavocytochrome P-450 BM3 from Bacillus megaterium.
    Munro AW; Noble MA; Turner KL; Chapman SK
    Biochem Soc Trans; 1998 Aug; 26(3):S212. PubMed ID: 9765931
    [No Abstract]   [Full Text] [Related]  

  • 18. Rational re-design of the substrate binding site of flavocytochrome P450 BM3.
    Ost TW; Miles CS; Murdoch J; Cheung Y; Reid GA; Chapman SK; Munro AW
    FEBS Lett; 2000 Dec; 486(2):173-7. PubMed ID: 11113461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are branched chain fatty acids the natural substrates for P450(BM3)?
    Cryle MJ; Espinoza RD; Smith SJ; Matovic NJ; De Voss JJ
    Chem Commun (Camb); 2006 Jun; (22):2353-5. PubMed ID: 16733577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of the stereo-selectivity of styrene epoxidation by cytochrome P450 BM3 using structure-based mutagenesis.
    Huang WC; Cullis PM; Raven EL; Roberts GC
    Metallomics; 2011 Apr; 3(4):410-6. PubMed ID: 21240430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.